Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2025-12-24 @ 3:06 PM
Study NCT ID:
NCT06621459
Status:
RECRUITING
Last Update Posted:
2024-10-01
First Post:
2024-09-27
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)
Sponsor:
University Hospital, Brest
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-09-26
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-27
First Submit QC Date:
None
Study First Post Date:
2024-10-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-10-01
Last Update Post Date Type:
ACTUAL